EW vs OSPN · P/E 47, rev $1.39B vs P/E 7.6, rev $243.2M
Edwards Lifesciences Corp (EW) versus OneSpan Inc (OSPN) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
OneSpan Inc (OSPN) is a software - infrastructure company listed on NASDAQ.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported OSPN revenue for 2025-12-31 was $243.2M. Net income was $72.9M. Revenue was up 0.0% from 2024-12-31 to 2025-12-31. OSPN currently screens at market cap $509.0M and trailing P/E 7.6.
EW currently screens at market cap $49.91B and trailing P/E 46.9. OSPN currently screens at market cap $509.0M and trailing P/E 7.6.
Not investment advice. Open the EW and OSPN stock pages for the full models.
Not investment advice.